Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Tsuchida K, Omori K, Yokoyama H, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H. Cho KY, et al. Among authors: manda n. Diabetes Obes Metab. 2020 Mar;22(3):458-462. doi: 10.1111/dom.13879. Epub 2019 Oct 13. Diabetes Obes Metab. 2020. PMID: 31486230 Free PMC article. Clinical Trial.
Step-up therapy with biphasic insulin aspart-70/30--Sapporo 1-2-3 study.
Yoshioka N, Kurihara Y, Manda N, Komori K, Kato M, Kijima H, Wada N, Yanagisawa K, Aoki S, Ono Y, Koike T. Yoshioka N, et al. Among authors: manda n. Diabetes Res Clin Pract. 2009 Jul;85(1):47-52. doi: 10.1016/j.diabres.2009.04.012. Epub 2009 May 7. Diabetes Res Clin Pract. 2009. PMID: 19427051 Free article.
A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2).
Nomoto H, Miyoshi H, Furumoto T, Oba K, Tsutsui H, Miyoshi A, Kondo T, Tsuchida K, Atsumi T, Manda N, Kurihara Y, Aoki S; SAIS Study Group. Nomoto H, et al. Among authors: manda n. PLoS One. 2015 Aug 18;10(8):e0135854. doi: 10.1371/journal.pone.0135854. eCollection 2015. PLoS One. 2015. PMID: 26284918 Free PMC article. Clinical Trial.
Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).
Kanatsuka A, Sato Y, Kawai K, Hirao K, Kobayashi M, Kashiwagi A; Japan Diabetes Clinical Data Management Study Group (JDDM); Abe N, Arai K, Fujiya H, Fukumoto Y, Dake F, Iizumi T, Ito M, Iwasaki K, Kanamori A, Kato S, Kato M, Kawara A, Kimura K, Chikamori K, Iemitsu K, Kou S, Kudo M, Kurihara Y, Lee G, Tsuruoka A, Manda N, Matoba K, Hayashi H, Minami M, Kuribayashi N, Miyazawa K, Chiba Y, Osonoi T, Nakamura S, Sasaki H, Komori K, Oishi M, Okada A, Okuguchi F, Yanagisawa M, Sugimoto H, Sugiyama H, Takai M, Takaki M, Takamura H, Takeda H, Takeda H, Tanaka K, Miwa T, Tomonaga O, Taguchi M, Yamazaki K, Wada T, Yagi N, Yamaoka K, Yuhara A. Kanatsuka A, et al. Among authors: manda n. J Diabetes Investig. 2016 May;7(3):386-95. doi: 10.1111/jdi.12430. Epub 2015 Nov 12. J Diabetes Investig. 2016. PMID: 27330726 Free PMC article.
A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1).
Nomoto H, Miyoshi H, Furumoto T, Oba K, Tsutsui H, Inoue A, Atsumi T, Manda N, Kurihara Y, Aoki S; SAIS Study Group. Nomoto H, et al. Among authors: manda n. PLoS One. 2016 Oct 6;11(10):e0164255. doi: 10.1371/journal.pone.0164255. eCollection 2016. PLoS One. 2016. PMID: 27711199 Free PMC article. Clinical Trial.
The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3).
Kitao N, Miyoshi H, Furumoto T, Ono K, Nomoto H, Miya A, Yamamoto C, Inoue A, Tsuchida K, Manda N, Kurihara Y, Aoki S, Nakamura A, Atsumi T; SAIS Study Group. Kitao N, et al. Among authors: manda n. Cardiovasc Diabetol. 2017 Oct 10;16(1):125. doi: 10.1186/s12933-017-0607-6. Cardiovasc Diabetol. 2017. PMID: 29017497 Free PMC article. Clinical Trial.
Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study.
Oita M, Miyoshi H, Ono K, Nakamura A, Cho KY, Nomoto H, Yamamoto K, Omori K, Manda N, Kurihara Y, Aoki S, Atsumi T. Oita M, et al. Among authors: manda n. Endocr J. 2018 Feb 26;65(2):141-150. doi: 10.1507/endocrj.EJ17-0303. Epub 2017 Oct 31. Endocr J. 2018. PMID: 29093280 Free article. Clinical Trial.
Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea.
Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H. Omori K, et al. Among authors: manda n. J Diabetes Investig. 2019 Mar;10(2):367-374. doi: 10.1111/jdi.12889. Epub 2018 Sep 15. J Diabetes Investig. 2019. PMID: 29963781 Free PMC article. Clinical Trial.
Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial.
Takase T, Nakamura A, Yamamoto C, Nomoto H, Miya A, Dannoura M, Cho KY, Kurihara Y, Manda N, Aoki S, Atsumi T, Miyoshi H. Takase T, et al. Among authors: manda n. J Diabetes Investig. 2019 May;10(3):699-705. doi: 10.1111/jdi.12906. Epub 2018 Sep 19. J Diabetes Investig. 2019. PMID: 30076787 Free PMC article. Clinical Trial.
43 results